with XPOVIO® (selinexor), the f‌irst and
only FDA-approved oral medicine of its kind

with XPOVIO® (selinexor), the f‌irst and
only FDA-approved oral medicine of its kind

What is XPOVIO?

XPOVIO® (selinexor) is a prescription medicine used:

  • in combination with dexamethasone to treat adults with multiple myeloma (MM) that has come back (relapsed) or that did not respond to previous treatment (refractory), and
    • who have received at least 4 prior therapies, and
    • whose disease did not respond (refractory) to at least 2 proteasome inhibitor medicines, at least 2 immunomodulatory agents, and an anti-CD38 monoclonal antibody medicine

What is the most important information I should know about XPOVIO?

Your healthcare provider will do blood tests before you start taking XPOVIO, and often during the first 3 months of treatment, and then as needed during treatment to monitor you for side ef‍fects. Your healthcare provider may change your dose of XPOVIO, stop your treatment for a period of time, or completely stop your treatment if you have certain side ef‍fects during treatment with XPOVIO.